StonvexLoading…
StonvexStonvexStonvexCore line items from BH.A's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $395.26M | $362.11M | $365.32M | $368.23M |
Operating Income | $-47.69M | $-8.15M | $64.85M | $-43.03M |
Net Income | $-37.49M | $-3.76M | $54.95M | $-32.02M |
EPS (Diluted) | $-143.86 | $-13.45 | $189.49 | $-107.43 |
Total Assets | $1.03B | $866.13M | $849.42M | $828.47M |
Total Liabilities | $501.95M | $293.17M | $250.09M | $272.91M |
Cash & Equivalents | $268.78M | $30.71M | $28.07M | $37.47M |
Free Cash Flow OCF − CapEx | $76.61M | $19.07M | $49.60M | $98.08M |
Shares Outstanding | Not available | Not available | Not available | Not available |